Infectious Disease News


The following articles appeared in the print edition of INFECTIOUS DISEASE NEWS.

Table of Contents
Cover Story

Push to end HIV epidemic in US complicated by ‘brain drain’

At Issue

What is the ‘new HIV’?

Hooked on ID

Hooked on ID with Aaron E. Glatt, MD, FACP, FIDSA, FSHEA

Eye on ID

Triple E: A severe zoonotic disease

Donald Kaye, MD, MACP; Thomas M. Yuill, PhD

Pharmacology Consult

Cefiderocol: A novel siderophore cephalosporin for MDR gram-negative infections

Leah Molloy, PharmD


Are outbreaks involving fresh produce, including romaine lettuce, on the rise?

WHO ‘concerned’ about potential rise in Ebola cases following attacks

‘Worthwhile to consider’: Does the world need a pentavalent flu vaccine?

Meeting News

New chemical formulation fights resistance in malaria bed nets

CURE ID crowdsources novel uses of existing drugs

Gavi to fund global stockpile of Ebola vaccines

Global report shows again that progress against malaria has slowed

Q&A: Infection prevention programs as a model for ASPs

In the Journals

Survey finds risky antibiotic use among adults

Text reminders, stigma support boost retention in HIV care

5-year study shows predominance of non-device-associated pneumonia

Acceptance of U=U on the rise among sexual minority men

Antibiotic stewardship programs in small hospitals often lack ID expertise

Bedaquiline-based treatment associated with favorable outcomes in patients with MDR-TB

California law cracking down on vaccine exemptions may have modest results

Current guidelines may lead to untreated UTIs in children

HCWs routinely contaminated with respiratory viruses

HIV test-and-treat policies in NYC nearly halve time to treatment

‘In this case, stability is not good’: HIV incidence at a standstill in US

Just 41% of eligible kids get MMR vaccine before travel outside US

Only 30% of youths with identified substance use tested for HCV

Pocket UV-C device can reduce stethoscope contamination

Prescribing practices for pregnant women with HIV not aligned with guidelines

Study finds high rates of STIs among new and persistent PrEP users

Typhoid conjugate vaccine 81% effective among kids in phase 3 trial